These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 2736315)
21. [Prognostic value of DNA ploidy of colorectal tumor cells]. Givel JC; de Quay N; Albe X; Vassilakos P Helv Chir Acta; 1989 Jan; 55(5):679-83. PubMed ID: 2715031 [TBL] [Abstract][Full Text] [Related]
22. Flow cytometric analysis of DNA content and cell kinetics in colorectal carcinoma. D'Agnano I; Cosimelli M; La Pera A; Cavaliere F; Mannella E; Giannarelli D; Cavaliere R; Zupi G Anticancer Res; 1993; 13(3):699-703. PubMed ID: 8317899 [TBL] [Abstract][Full Text] [Related]
23. DNA flow cytometry of colorectal carcinoma: correlation of DNA stemlines with other prognostic indices. Bawani M; Tibrewala S; Copur S; Harris D; Gilman-Sachs A Am J Gastroenterol; 1991 Feb; 86(2):191-5. PubMed ID: 1992633 [TBL] [Abstract][Full Text] [Related]
24. Analysis of genetic alterations, classified according to their DNA ploidy pattern, in the progression of colorectal adenomas and early colorectal carcinomas. Sugai T; Takahashi H; Habano W; Nakamura S; Sato K; Orii S; Suzuki K J Pathol; 2003 Jun; 200(2):168-76. PubMed ID: 12754737 [TBL] [Abstract][Full Text] [Related]
25. Numerical abnormalities of chromosomes 17 and 18 in sporadic colorectal cancer: Incidence and correlation with clinical and biological findings and the prognosis of the disease. Garcia J; Duran A; Tabernero MD; Garcia Plaza A; Flores Corral T; Najera ML; Gomez-Alonso A; Orfao A Cytometry B Clin Cytom; 2003 Jan; 51(1):14-20. PubMed ID: 12500293 [TBL] [Abstract][Full Text] [Related]
26. Gastric cancer cell DNA content correlates with early and late results after gastrectomy. Carlini M; Garofalo A; Rinaldi G; D'Agnano I; D'Angelo C; Zupi G; Vecchione A; Santoro E Int Surg; 1994; 79(2):114-9. PubMed ID: 7928145 [TBL] [Abstract][Full Text] [Related]
27. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma. Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234 [TBL] [Abstract][Full Text] [Related]
28. The DNA content of colorectal carcinomas: an analysis of the heterogeneity of aneuploidy and correlation with immunopathological parameters. Zaloudík J; Moore M; Hasleton PS Neoplasma; 1988; 35(4):389-401. PubMed ID: 3054589 [TBL] [Abstract][Full Text] [Related]
29. Clinical and pathological significance of numerical aberrations of chromosomes 11 and 17 in colorectal neoplasms. Tagawa Y; Yasutake T; Sawai T; Nanashima A; Jibiki M; Morinaga M; Akama F; Nakagoe T; Ayabe H Clin Cancer Res; 1997 Sep; 3(9):1587-92. PubMed ID: 9815847 [TBL] [Abstract][Full Text] [Related]
30. Alteration of DNA ploidy status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal cancer. Lammering G; Taher MM; Gruenagel HH; Borchard F; Porschen R Clin Cancer Res; 2000 Aug; 6(8):3215-21. PubMed ID: 10955806 [TBL] [Abstract][Full Text] [Related]
31. Prognostic significance of DNA content abnormalities in young patients with colorectal cancer. Heimann TM; Martinelli G; Szporn A; Kurtz RJ; Quish A; Miller F; Oh SC; Fasy T Ann Surg; 1989 Dec; 210(6):792-5. PubMed ID: 2589893 [TBL] [Abstract][Full Text] [Related]
32. Histologic parameters and DNA ploidy as predictors of survival in stage B adenocarcinoma of colon and rectum. Robey-Cafferty SS; el-Naggar AK; Grignon DJ; Cleary KR; Ro JY Mod Pathol; 1990 May; 3(3):261-6. PubMed ID: 2362936 [TBL] [Abstract][Full Text] [Related]
33. The importance of heterogeneity and of multiple site sampling in the prospective determination of deoxyribonucleic acid flow cytometry. Stipa S; Danesi DT; Modini C; Cicconetti F; Mauro F; Schillaci A; Mecozzi A; Nicolanti V; Stipa F; Mancini M Surg Gynecol Obstet; 1993 May; 176(5):427-34. PubMed ID: 8386859 [TBL] [Abstract][Full Text] [Related]
34. Multivariate analysis of the prognostic significance of DNA-ploidy and S-phase fraction in ovarian cancer determined by flow cytometry following detection of cytokeratin-labeled tumor cells. Kimmig R; Wimberger P; Hillemanns P; Kapsner T; Caspari C; Hepp H Gynecol Oncol; 2002 Jan; 84(1):21-31. PubMed ID: 11748971 [TBL] [Abstract][Full Text] [Related]
35. [DNA as a prognostic factor in colorectal cancer. A retrospective analysis of 34 patients]. Bianchi A; Mallofre C; Serrano A; Suñol J; Barja J; Ubach M Rev Esp Enferm Dig; 1993 Aug; 84(2):100-4. PubMed ID: 8398367 [TBL] [Abstract][Full Text] [Related]
36. Overexpression of ras is an independent prognostic factor in colorectal adenocarcinoma. Sun XF; Ekberg H; Zhang H; Carstensen JM; Nordenskjöld B APMIS; 1998 Jun; 106(6):657-64. PubMed ID: 9725799 [TBL] [Abstract][Full Text] [Related]
37. Flow cytometric DNA and clinicopathologic analysis of Dukes' A&B colonic adenocarcinomas: a retrospective study. Visscher DW; Zarbo RJ; Ma CK; Sakr WA; Crissman JD Mod Pathol; 1990 Nov; 3(6):709-12. PubMed ID: 2263595 [TBL] [Abstract][Full Text] [Related]
38. Stereologic estimates of volume-weighted mean nuclear volume in colorectal adenocarcinoma: correlation with histologic grading, Dukes' staging, cell proliferation activity and p53 protein expression. Martín R; Nieto S; Santamaría L Gen Diagn Pathol; 1997 Jul; 143(1):29-38. PubMed ID: 9269906 [TBL] [Abstract][Full Text] [Related]
39. Flow cytometric evaluation of early invasive cervical cancer. Connor JP; Miller DS; Bauer KD; Murad TM; Rademaker AW; Lurain JR Obstet Gynecol; 1993 Mar; 81(3):367-71. PubMed ID: 8437788 [TBL] [Abstract][Full Text] [Related]